Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-12-10 00:00:00 ET · period of report 2024-12-09 · accession 0001968202-24-000138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-10 | 2024-12-09 | REGN | STAHL NEIL | EVP Research, Development | F - Tax | $787.00 | -466 | 49.1K | -0.9% | -$366.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | F | D | 466 | $787.00 | 49,133 | D | — | — |